MyFinsight
Home
Blog
About
Contact
Download
Download image
Interest and investment
income
$2,498K
Net loss
-$31,643K
Total other income,
net
$2,461K
Other expense, net
-$37K
Loss from operations
-$34,104K
Collaboration revenue
$706K
Total operating
expenses
$34,810K
Research and development
$24,149K
General and
administrative
$10,661K
Back
Back
Income Statement
source: myfinsight.com
Astria Therapeutics, Inc. (ATXS)
Astria Therapeutics, Inc. (ATXS)